ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: TH-PO775

A Population-Based Assessment of Kidney Function and the Risk of Heart Failure Among Older Adults

Session Information

Category: Geriatric Nephrology

  • 1200 Geriatric Nephrology


  • Douros, Antonios, McGill University, Montreal, Quebec, Canada
  • Schneider, Alice, Charite Universitatsmedizin Berlin, Berlin, Berlin, Germany
  • Mielke, Nina, Charite Universitatsmedizin Berlin, Berlin, Berlin, Germany
  • Kuhlmann, Martin K., Vivantes Netzwerk fur Gesundheit GmbH, Berlin, Berlin, Germany
  • van der Giet, Markus, Charite Universitatsmedizin Berlin, Berlin, Berlin, Germany
  • Ebert, Natalie, Charite Universitatsmedizin Berlin, Berlin, Berlin, Germany
  • Schaeffner, Elke, Charite Universitatsmedizin Berlin, Berlin, Berlin, Germany

Decreased kidney function (KF) increases the risk of heart failure (HF) and other adverse cardiovascular (CV) outcomes and death. However, the role of KF in this regard among old and very old adults is poorly understood. This is an important knowledge gap since the decline of KF in advanced age can affect both healthy and multimorbid individuals. Thus, our population-based study assessed whether decreased KF is associated with an increased risk of HF, CV and all-cause mortality in a prospective cohort of community-dwelling older adults.


Participants of the Berlin Initiative Study (BIS), all aged ≥70 years, with baseline estimated glomerular filtration rate (eGFRBIS2) and no prior HF were followed from baseline (2009-2011) until the occurrence of a study outcome (hospitalization for HF [HHF], CV death, all-cause mortality) or 12/2020. HHF was defined via inpatient diagnostic codes, and mortality outcomes were defined via claims data, death certificates, and hospital discharge notes. Potential confounders included demographics, body mass index, alcohol consumption, smoking, physical exercise, education, income, comedications and comorbidities, measured at baseline using face-to-face interviews and claims data. Time-dependent Cox models estimated hazard ratios (HRs) with 95% confidence intervals (CIs) of the outcomes associated with decreased KF (eGFRBIS2 <60mL/min/1.73m2) compared with retained KF (eGFRBIS2 ≥60mL/min/1.73m2). eGFR values were updated biennialy.


Our cohort included 1466 HF free older adults (mean age 79 years; 55% female). Compared with retained KF, decreased KF was not associated with an increased risk of HHF (HR, 1.17; CI, 0.92-1.49), but was associated with increased risks of CV death (HR, 1.59; CI, 1.01-2.50), and all-cause mortality (HR, 1.33; CI, 1.02-1.72) (Figure).


Our population-based study showed that decreased KF is associated with an increased risk of CV and all-cause death among older adults. The role of HF in this association seems to be limited.

Risk of outcomes with decreased KF among older adults


  • Private Foundation Support